Skip to content

Understanding the effects of bacteria in the blood of critically ill patients

Sepsis-induced stress and Network Analysis on Pathogen Expression of stress-combat genes: the SNAPE study - SNAPE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039393
Enrollment
15
Registered
2022-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Sponsors

Manipal Academy of Higher Education Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1: 1. Adult patients (=18 years) admitted to ICU with preexisting septicaemia and sepsis 2. SOFA score =2 3. Needs vasopressor therapy to elevate mean arterial pressure =65 mmHg and lactate >2mmol/L (18mg/dL) despite adequate fluid resuscitation 4. Culture positivity for E. coli within 48 hours from the time of first blood sample drawn for culture testing Group 2: 1. Adult patients (=18 years) who were admitted to wards/ICU with preexisting bacteremia 2. SOFA score 3. Culture positivity for E. coli within 48 hours from time of first blood sample drawn for culture testing. Group 3: 1. Healthy adult volunteers (=18 years and not admitted to the hospital) or those with well-controlled underlying conditions (hypertension, diabetes etc.) 2. Able and willing to complete the informed consent process 3. Volunteer must agree to have blood stored and used for this study (within the scope of the approved duration and purposes of this study)

Exclusion criteria

Exclusion criteria: Group 1 and 2: 1. Pregnant or lactating women 2. Documented immunocompromised clinical status 3. Chronic kidney disease and/or on dialysis 4. Blood transfusion >4 units in the past week 5. Undergone surgeries, grafts, transfusions or extra-corporeal circulation in the last 6 months 6. Prolonged antibiotic usage in the last 3 months 7. History of sepsis/septic shock in the last 6 months 8. Anticipated hospitalization of =2 days 9. Second admission or transfer from other hospital ICUs or previous enrolment in the study 10. Restricted liberty or under legal protection 11. Inability to get consent Group 3: 1. Pregnant or breast-feeding 2. Infected with any infectious diseases 3. Hemophilia, severe coagulation disorders or impaired venous access 4. Prolonged antibiotic usage in the last 3 months 5. History of sepsis/septic shock in the last 6 months

Design outcomes

Primary

MeasureTime frame
Total Protein-Protein interactionsTimepoint: baseline

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactVenkat Abhiram Earny

Kasturba Medical College, Manipal

earny.abhiram@gmail.com7013776969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026